DWM
BIO icon

Dakota Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Dakota Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,281
Closed -$459K – 664
2023
Q3 		$459K Sell
1,281
-7
-0.5% -$2.7K 0.02% 425
2023
Q2 		$488K Sell
1,288
-59
-4% -$24K 0.02% 390
2023
Q1 		$645K Buy
1,347
+70
+5% +$32.8K 0.04% 308
2022
Q4 		$537K Buy
1,277
+217
+20% +$87.6K 0.04% 340
2022
Q3 		$443K Buy
1,060
+270
+34% +$135K 0.04% 356
2022
Q2 		$391K Buy
+790
New +$411K 0.04% 322

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dakota Wealth Management's BIO Position: Q4 2023 in Review

Dakota Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 1,281 shares — an estimated $459K sold.

Dakota Wealth Management first reported a position in BIO in Q2 2022 and held it in 6 quarters. The position peaked at $645K in Q1 2023. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Dakota Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Dakota Wealth Management sold 1,281 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $459K.
  • Dakota Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 6 quarters.
  • Dakota Wealth Management's Bio-Rad Laboratories Class A position peaked at $645K in Q1 2023.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Dakota Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.